PACS Group Receives 'Moderate Buy' Rating from Analysts

Company's stock performance and outlook discussed by brokerages

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

PACS Group, Inc. (NYSE:PACS) has received a consensus 'Moderate Buy' rating from the five brokerages covering the firm, according to a report from Marketbeat.com. Two analysts have rated the stock with a 'hold' recommendation, while three have given it a 'buy' recommendation. The average 12-month price target among the analysts is $44.50.

Why it matters

The 'Moderate Buy' rating and price target from analysts suggest potential upside for PACS Group's stock, which could generate investor interest and buying pressure. However, the mixed ratings also indicate some uncertainty around the company's near-term performance and outlook.

The details

The analysts' ratings and price targets for PACS Group were based on a review of the company's recent financial results and business developments. Some key factors cited include the company's revenue growth targets, operational quality metrics, and integration activity from recent acquisitions. However, the company also faced some mixed quarterly results that triggered technical selling pressure on the stock.

  • PACS Group reported its full fiscal year and Q4 2025 results on March 2, 2026.

The players

PACS Group, Inc.

A company that operates skilled nursing facilities, assisted living facilities, and independent senior care facilities in the United States.

Royal Bank of Canada (RBC)

A financial institution that covers PACS Group and raised its price target to $52 while maintaining an 'outperform' rating on the stock.

UBS Group

A financial firm that reiterated a 'buy' rating on PACS Group but lowered its price target to $42.

Weiss Ratings

A ratings agency that reaffirmed a 'hold (c-)' rating on PACS Group's shares.

JPMorgan Chase & Co.

A bank that initiated coverage on PACS Group with an 'overweight' rating and $44 price target.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

The mixed analyst views on PACS Group highlight the uncertainty around the company's near-term performance, but the overall 'Moderate Buy' rating and price targets suggest potential upside if the company can execute on its growth plans and operational improvements.